SCHEMBL7299343

SCHEMBL7299343

CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)OCc1cccnc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.77
CYP3A4 P08684 18/20 0.62
CYP2D6 P10635 4/20 0.59
CYP2C19 P33261 3/20 0.59
CYP2C9 P11712 3/20 0.59
MEN1 O00255 1/20 0.59
SLC22A2 O15244 1/20 0.59
SLC22A1 O15245 1/20 0.59
ABCC3 O15438 1/20 0.59
ABCC4 O15439 1/20 0.59
MLNR O43193 1/20 0.59
NR1I2 O75469 1/20 0.59
SLCO2B1 O94956 1/20 0.59
ABCB11 O95342 1/20 0.59
ALDH1A1 P00352 1/20 0.59
PGR P06401 1/20 0.59
ABCB1 P08183 1/20 0.59
HTR1A P08908 1/20 0.59
ADRA2A P08913 1/20 0.59
ADORA3 P0DMS8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301328 0.97 CA2 (0.77) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7431901 0.97 CA2 (0.77) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7307766 0.94 CA2 (0.68) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7313856 0.94 CA2 (0.77) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7298711 0.92 CA2 (0.68) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7305428 0.91 CA2 (0.64) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7307791 0.91 CA2 (0.77) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL2771252 0.91 CA2 (0.62) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL13240259 0.91 CA2 (0.62) CA2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7302611 0.91 CYP3A4 (0.64) CA2CYP3A4CYP2D6CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP claimed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP claimed
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed